ASTERIAS BIOTHERAPEUTICS, INC. filed this PRE 14A on 20180420

Document Outline
Entire Document (3.8 MB)
Subdocument - PRE 14A - PRE 14A
  Page 1 - UNITED STATES SECURITIES AND EXCHANGE COMMISSION
  Page 2 - N/A
  Page 3 - TABLE OF CONTENTS
  Page 4 - NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
  Page 5 - PROXY STATEMENT
  Page 6 - Q: What if I abstain from voting on a matter?
  Page 7 - Q: What if any matters not mentioned in the Notice of Annual Meeting or this proxy statement come up
  Page 8 - PROPOSAL NO. 1 - ELECTION OF DIRECTORS
  Page 9 - Alfred D. Kingsley, 75
  Page 10 - Michael H. Mulroy, 52,
  Page 11 - Michael D. West, Ph.D., 64
  Page 12 - Board Recommendation
  Page 13 - CORPORATE GOVERNANCE
  Page 14 - Committees of the Board
  Page 15 - Compensation Committee
  Page 16 - Clinical and Process Development Committee
  Page 17 - Executive Officers
  Page 18 - EXECUTIVE COMPENSATION
  Page 19 - Stock Options Outstanding at Year End
  Page 20 - Employment Agreements
  Page 21 - SECURITIES AUTHORIZED FOR ISSUANCE UNDER 2013 EQUITY INCENTIVE PLAN
  Page 22 - PROPOSAL NO. 2 - APPROVAL OF THE AMENDMENT TO THE CERTIFICATE OF
  Page 23 - Possible Anti-Takeover Effects
  Page 24 - PRINCIPAL STOCKHOLDERS
  Page 25 - Security Ownership of Management
  Page 26 - Certain Relationships and Related Transactions
  Page 27 - COMPLIANCE WITH SECTION 16(a) OF THE SECURITIES EXCHANGE ACT OF 1934
  Page 28 - PROPOSAL NO. 3 - RATIFICATION OF THE SELECTION OF OUR INDEPENDENT REGISTERED
  Page 29 - Pre-Approval of Audit and Permissible Non-Audit Services
  Page 30 - PROPOSAL NO. 4 - ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE
  Page 31 - PROPOSALS OF STOCKHOLDERS
  Page 32 - HOW TO ATTEND THE ANNUAL MEETING
  Page 33 - APPENDIX A
  Page 34 - N/A
  Page 35 - N/A